We have developed potent ebselen-based compounds, MR6-8-2 and MR6-26-2 that stabilise dimers of ALS-associated mutants of SOD1 and have validated the neuroprotective activity in a mouse cell-based model expressing G93A SOD1 mutation25. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.